Table 2.
Effectiveness of PRP in augmentation of rotator cuff tear repairs.
Study | Study design | Patients | Tear type | Outcome | Use of PRP | ||
---|---|---|---|---|---|---|---|
Total | PRP | Control | |||||
Jo et al. (46) | RCT | 48 | 24 | 24 | Large to massive | P-PRP significantly improved structural outcomes. No significant difference in clinical outcomes except the overall shoulder function after 1-year FU | + (P-PRP) |
Jo et al. (47) | RCT | 74 | 37 | 37 | Medium to large | P-PRP significantly improved the structural quality but not the speed of healing | + (P-PRP) |
D’Ambrosi et al. (49) | RCT | 40 | 20 | 20 | Medium to large | L-PRP leads to a reduction in pain during a short-term follow-up | + (L-PRP) |
Wang et al. (50) | RCT | 60 | 30 | 30 | Full thickness | P-PRP treatment does not improve early tendon–bone healing or functional recovery | – (P-PRP) |
Ebert et al. (51) | RCT | 60 | 30 | 30 | Full thickness | Maximal abduction strength was greater in the midterm after P-PRP. Repeated P-PRP has no additional benefit to tendon integrity | 0 (P-PRP) |
Flury et al. (52) | RCT | 120 | 60 | 30 RV | All tear size | No significantly improved function at 3, 6 and 24 months after arthroscopic repair compared with control patients | – |
Malavolta et al. (53) | RCT | 54 | 26 | 25 | Small to medium | P-PRP did not promote better clinical or structural results at 60-month follow-up | – (P-PRP) |
Pandey et al. (54) | RCT | 102 | 52 | 50 | Medium to large | P-PRP improves clinical and structural outcome in large cuff tears at minimum 2-year FU | + (P-PRP) |
+, support the use of PRP; –, does not support the use of PRP; 0, neither support nor against PRP use.
FU, follow-up; RV, ropivacaine.